
NYSEHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
366 US$
+2.73 US$ · +0.75%
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
الإغلاق السابق
366 US$
+2.73 US$ · +0.75%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
نطاق اليوم
السعر الحالي 366 US$
نطاق 52 أسبوعًا
السعر الحالي 366 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
49
قيمة عادلة
المشاعر
70
صعودي
المخاطر
23
مخاطر متوسطة
الزخم
57
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
نطاق اليوم
السعر الحالي 366 US$
نطاق 52 أسبوعًا
السعر الحالي 366 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 3.07 مليار USD | 2.89 مليار USD | 2.95 مليار USD | 2.89 مليار USD | 2.83 مليار USD |
| تكلفة البضاعة المباعة | 1.97 مليار USD | 1.89 مليار USD | 1.82 مليار USD | 1.75 مليار USD | 1.66 مليار USD |
| الربح الإجمالي | 1.1 مليار USD | 1 مليار USD | 1.13 مليار USD | 1.14 مليار USD | 1.17 مليار USD |
| البحث والتطوير | 74.3 مليون USD | 69.1 مليون USD | 68.4 مليون USD | 58.5 مليون USD | 52.8 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 393.1 مليون USD | 338.5 مليون USD | 353.4 مليون USD | 316.9 مليون USD | 361.9 مليون USD |
| نفقات التشغيل | 485.9 مليون USD | 407.6 مليون USD | 421.8 مليون USD | 375.4 مليون USD | 414.7 مليون USD |
| دخل الفوائد | 17.7 مليون USD | 19.6 مليون USD | 28 مليون USD | 5.1 مليون USD | 1 مليون USD |
| مصاريف الفوائد | 600 ألف USD | 2.9 مليون USD | 8.8 مليون USD | 7.6 مليون USD | 8.5 مليون USD |
| الاستهلاك والإطفاء | 171.4 مليون USD | 155.4 مليون USD | 137.3 مليون USD | 120.6 مليون USD | 122.3 مليون USD |
| الدخل التشغيلي | 617.4 مليون USD | 594.6 مليون USD | 710.9 مليون USD | 763.5 مليون USD | 758.7 مليون USD |
| صافي الدخل | 493.7 مليون USD | 492.7 مليون USD | 593.4 مليون USD | 585.9 مليون USD | 661.8 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
419.5 US$
ارتفاع محتمل بنسبة 14.62%صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T49.74 مليار0.04%129.35 ترليون JPY0.09%122,850 JP¥+0.12%
Vanguard Morningstar Total Stock Market ETFVTI765.75 مليون0.03%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard S&P 500 ETFVOO640.24 مليون0.04%1.8 ترليون USD0.03%715.59 US$+0.61%
Vanguard Morningstar Mid-Cap ETFVO521.26 مليون0.23%226.4 مليار USD0.03%81.14 US$+0.92%
iShares Core S&P 500 ETFIVV339.91 مليون0.04%896.44 مليار USD0.03%781.97 US$+0.60%
Vanguard Morningstar Growth ETFVUG318.14 مليون0.08%384.6 مليار USD0.03%91.97 US$+0.72%
State Street SPDR S&P 500 ETFSPY314.17 مليون0.04%817.2 مليار USD0.09%778.57 US$+0.60%
Invesco S&P 500 Equal Weight ETFRSP213.31 مليون0.22%97.78 مليار USD0.20%213.04 US$+0.55%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPY
Invesco S&P 500 Equal Weight ETFRSPالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.